GLENMEDE TRUST CO NA - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 39 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$5,000
-16.7%
4,200
+0.8%
0.00%
Q2 2020$6,0000.0%4,1660.0%0.00%
Q1 2020$6,0000.0%4,1660.0%0.00%
Q4 2019$6,000
-57.1%
4,1660.0%0.00%
Q3 2019$14,000
-6.7%
4,1660.0%0.00%
Q2 2019$15,000
-65.1%
4,1660.0%0.00%
Q1 2019$43,0000.0%4,1660.0%0.00%
Q4 2018$43,000
-12.2%
4,1660.0%0.00%
Q2 2018$49,000
-10.9%
4,1660.0%0.00%
Q1 2018$55,0000.0%4,1660.0%0.00%
Q4 2017$55,0004,1660.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
BVF INC/IL 785,950$9,314,0000.91%
Morse Asset Management, Inc 177,500$2,103,0000.58%
PARSONS CAPITAL MANAGEMENT INC/RI 281,213$3,332,0000.38%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 73,000$860,0000.33%
TIEDEMANN ADVISORS, LLC 412,049$4,883,0000.31%
Private Capital Advisors, Inc. 52,335$620,0000.19%
SECTORAL ASSET MANAGEMENT INC 131,656$1,560,0000.17%
Lee Financial Co 18,750$222,0000.05%
Baker Brothers Advisors 373,144$4,422,0000.03%
Alyeska Investment Group, L.P. 200,000$2,370,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders